| Old Articles: <Older 8951-8960 Newer> |
|---|
 |
Chemistry World
October 8, 2014
Phillip Broadwith |
Actavis boosts antibiotics with Durata buyout Pharma major Actavis has agreed to buy antibacterials specialist Durata Therapeutics for $675 million.   |
Chemistry World
October 8, 2014
Rebecca Trager |
US tax changes ripple into merger deals The tightened tax rules are pressuring pharmaceutical and medical devices companies to reconsider deals announced recently, according to financial analysts. |
Chemistry World
October 7, 2014
Phillip Broadwith |
Becton Dickinson to buy CareFusion for $12bn Medical devices giant Becton Dickinson has agreed to buy automation and infection prevention specialist CareFusion for over $12 billion. |
Chemistry World
October 5, 2014
Andy Extance |
Tea tonic peps up tumor treatment Researchers in Singapore and the US have brewed up a green tea-based cancer drug delivery system where both the drug and its carrier fight tumor growth. |
Chemistry World
October 1, 2014
Phillip Broadwith |
J&J to buy antiviral specialist Alios Johnson and Johnson has agreed to buy antiviral specialist Alios BioPharma for $1.75 billion |
Chemistry World
October 1, 2014
Rebecca Trager |
Researcher imprisoned for poisoning ex-lover Ana Gonzalez-Angulo was found guilty of poisoning her ex-lover George Blumenschein -- another doctor who was her colleague at University of Texas MD Anderson Cancer Center in Houston, Texas. |
CIO
September 29, 2014
Phil Schneidermeyer |
Pharma CIO Taps Into the Silicon Valley Talent Pool AstraZeneca's global talent network includes a new center designed to recruit 'tech brains' from the Bay Area. |
Chemistry World
September 30, 2014
Phillip Broadwith |
Lumara splits and sells to AMAG and Perrigo Women's health specialist Lumara is to be split in two and sold to AMAG and consumer healthcare firm Perrigo. |
Chemistry World
September 30, 2014 |
Transparency measures forced on pharma Previous misdemeanors are compelling the pharmaceutical industry to be more open with financial information and clinical data. |
Chemistry World
September 25, 2014
Phillip Broadwith |
India backs off drug pricing controls The Indian government has intervened in an argument over pharmaceutical pricing controls. |
| <Older 8951-8960 Newer> Return to current articles. |
